Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Sanders

Showing results (721-730 of 915) with videos related to

Pageof 92
Sort By:
Neuron|May 27, 2014
Distinct tau prion strains propagate in cells and mice and define different tauopathiesDavid W Sanders, Sarah K Kaufman, Sarah L DeVos, et al.
Diagnostic Microbiology and Infectious Disease|February 26, 2022
Diagnostic performance of two serological assays for the detection of SARS-CoV-2 specific antibodies: surveillance after vaccinationAlba Fresco-Taboada, Marga García-Durán, Cristina Aira, et al.
Immunity|August 2, 2023
Heavy-chain CDR3-engineered B cells facilitate in vivo evaluation of HIV-1 vaccine candidatesWenhui He, Tianling Ou, Nickolas Skamangas, et al.
Immunity|November 26, 2020
Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by AvidityHejun Liu, Nicholas C Wu, Meng Yuan, et al.
Journal of Virology|April 7, 2017
Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence ChangesRajesh P Ringe, Gabriel Ozorowski, Anila Yasmeen, et al.
Virology|March 23, 2010
Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry functionDirk Eggink, Mark Melchers, Manfred Wuhrer, et al.
Cell Reports|September 7, 2024
Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responsesPhilip J M Brouwer, Hailee R Perrett, Tim Beaumont, et al.
Plos Pathogens|August 15, 2024
Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responsesKarlijn van der Straten, Denise Guerra, Gius Kerster, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2023
Proton therapy for the management of localized prostate cancer: Long-term clinical outcomes at a comprehensive cancer centerAlan J Sosa, Howard D Thames, Jeremiah W Sanders, et al.
Journal of Proteome Research|February 9, 2018
Integrity of Glycosylation Processing of a Glycan-Depleted Trimeric HIV-1 Immunogen Targeting Key B-Cell LineagesAnna-Janina Behrens, Abhinav Kumar, Max Medina-Ramirez, et al.
Pageof 92

Showing results (721-730 of 915) with videos related to

Sort By:
Pageof 92
Neuron|May 27, 2014
Distinct tau prion strains propagate in cells and mice and define different tauopathiesDavid W Sanders, Sarah K Kaufman, Sarah L DeVos, et al.
Diagnostic Microbiology and Infectious Disease|February 26, 2022
Diagnostic performance of two serological assays for the detection of SARS-CoV-2 specific antibodies: surveillance after vaccinationAlba Fresco-Taboada, Marga García-Durán, Cristina Aira, et al.
Immunity|August 2, 2023
Heavy-chain CDR3-engineered B cells facilitate in vivo evaluation of HIV-1 vaccine candidatesWenhui He, Tianling Ou, Nickolas Skamangas, et al.
Immunity|November 26, 2020
Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by AvidityHejun Liu, Nicholas C Wu, Meng Yuan, et al.
Journal of Virology|April 7, 2017
Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence ChangesRajesh P Ringe, Gabriel Ozorowski, Anila Yasmeen, et al.
Virology|March 23, 2010
Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry functionDirk Eggink, Mark Melchers, Manfred Wuhrer, et al.
Cell Reports|September 7, 2024
Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responsesPhilip J M Brouwer, Hailee R Perrett, Tim Beaumont, et al.
Plos Pathogens|August 15, 2024
Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responsesKarlijn van der Straten, Denise Guerra, Gius Kerster, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2023
Proton therapy for the management of localized prostate cancer: Long-term clinical outcomes at a comprehensive cancer centerAlan J Sosa, Howard D Thames, Jeremiah W Sanders, et al.
Journal of Proteome Research|February 9, 2018
Integrity of Glycosylation Processing of a Glycan-Depleted Trimeric HIV-1 Immunogen Targeting Key B-Cell LineagesAnna-Janina Behrens, Abhinav Kumar, Max Medina-Ramirez, et al.
Pageof 92